The Deficiency Letters have no immediate impact on the Company's listing on the Nasdaq Capital Market. Pursuant to Rules 5810 (c) (3) (A) and 5810 (c) (3) (D) of the Nasdaq Listing Rules, respectively ...
NEW YORK & LONDON & PARIS--(BUSINESS WIRE)--Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company ...
ALAMEDA, Calif.--(BUSINESS WIRE)--AgeX Therapeutics , Inc. (“AgeX”: NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, announced today that on ...
BEIJING, Jan. 05, 2024 (GLOBE NEWSWIRE) -- AirNet Technology Inc. (ANTE), formerly known as AirMedia Group Inc. (the “Company”) (Nasdaq: ANTE), today announced that it received a notification letter ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results